Leuprex 3, 5mg Implant Ireland - English - HPRA (Health Products Regulatory Authority)

leuprex 3, 5mg implant

rowex ltd - leuprorelin acetate - implant - 3 mg, 5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

LEUPROLIDE ACETATE INJECTION LIQUID Canada - English - Health Canada

leuprolide acetate injection liquid

novopharm limited - leuprolide acetate - liquid - 5mg - leuprolide acetate 5mg - antineoplastic agents

ZEULIDE DEPOT POWDER FOR SUSPENSION, SUSTAINED-RELEASE Canada - English - Health Canada

zeulide depot powder for suspension, sustained-release

verity pharmaceuticals inc. - leuprolide acetate - powder for suspension, sustained-release - 3.75mg - leuprolide acetate 3.75mg - antineoplastic agents

LUCRIN DEPOT 3 Australia - English - Department of Health (Therapeutic Goods Administration)

lucrin depot 3

abbvie pty ltd - leuprorelin acetate, quantity: 22.5 mg - injection, modified release - excipient ingredients: mannitol; polylactic acid - in the palliative treatment of metastatic or locally extensive prostatic cancer. (stage c and d).

LUCRIN DEPOT 7.5mg powder for injection prefilled dual-chamber syringe with 23 G needle Australia - English - Department of Health (Therapeutic Goods Administration)

lucrin depot 7.5mg powder for injection prefilled dual-chamber syringe with 23 g needle

abbvie pty ltd - leuprorelin acetate, quantity: 7.5 mg - injection, modified release - excipient ingredients: gelatin; mannitol; polyglactin - lucrin depot 7.5 mg injection and lucrin depot 3 month 22.5mg injection and lucrin depot 4 month 30mg injection are indicated in the palliative treatment of metastatic or locally extensive prostatic cancer (stage c and d).

PROSTAP 3 DCS 11.25 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe Ireland - English - HPRA (Health Products Regulatory Authority)

prostap 3 dcs 11.25 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe

takeda products ireland ltd - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection in pre-filled syringe - 11.25 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

PROSTAP 6 DCS 30 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe Ireland - English - HPRA (Health Products Regulatory Authority)

prostap 6 dcs 30 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe

takeda products ireland ltd - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection in pre-filled syringe - 30 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

PROSTAP SR DCS 3.75 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled Syringe Ireland - English - HPRA (Health Products Regulatory Authority)

prostap sr dcs 3.75 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe

takeda products ireland ltd - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection in pre-filled syringe - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

Lutrate 1 month Depot 3.75 mg powder and solvent for prolonged-release suspension for injection Ireland - English - HPRA (Health Products Regulatory Authority)

lutrate 1 month depot 3.75 mg powder and solvent for prolonged-release suspension for injection

gp-pharm, s.a. - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

Depo-Eligard 22.5 mg inj. sol. (pwdr. + solv.) s.c. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

depo-eligard 22.5 mg inj. sol. (pwdr. + solv.) s.c. pre-filled syr.

recordati industria chimica e farmaceutica s.p.a. - leuprorelin acetate 22,5 mg - eq. leuprorelin 20,87 mg - powder and solvent for solution for injection - 22,5 mg - leuprorelin acetate 22.5 mg - leuprorelin